Analysts Viewpoint
BioAtla Inc [BCAB] Records 200-Day SMA of $2.31
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
BioAtla Inc’s filing revealed that its Director MCBRINN SYLVIA acquired Company’s shares for reported $9320.0 on Dec 26 ’23. In
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
BioAtla Inc’s recent filing unveils that its Director MCBRINN SYLVIA acquired Company’s shares for reported $9320.0 on Dec 26 ’23.
BioAtla Inc’s recent filing unveils that its Director MCBRINN SYLVIA acquired Company’s shares for reported $9320.0 on Dec 26 ’23.